Aeneas Yeo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aeneas Yeo has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Samuel Brookes
Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide SA, Australia
2 shared publications - Alex Chatburn
Adelaide University
1 shared publication Chien-Li Holmes-Liew
1 shared publicationHelen Whitford
1 shared publication- Kate Diana Lynch
Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
1 shared publication - Kevin Seow
Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide SA, Australia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Transplantation
- Vol. 2026 (1)
Recurrent Cryptogenic Ulcerative Tracheobronchitis 6 Years After Lung Transplantation: Case Report
Background: Tracheobronchitis is an uncommon pattern of airway disease and is typically caused by infection, inhalation injury, infiltrative disorders and more rarely, systemic autoimmune disease. Rarer again is the development of bronchial webbing following tracheobronchitis. The underlying aetiology is usually identified through biopsy, culture or a detailed clinical history. We present a case of cryptogenic ulcerative tracheobronchitis with bronchial webbing being successfully managed by bilateral lung transplantation that has, however, been complicated by recurrence. Case Presentation: In 2019, Crowhurst et al. detailed the case of a patient who presented with dyspnoea and haemoptysis. Bronchoscopy revealed ulcerative tracheobronchitis and he subsequently formed recurrent web‐like stenoses of the central bronchi, leading to rapidly progressive type 2 respiratory failure; he received bilateral sequential lung transplantation for definitive management. At the time of transplant, the presumed diagnosis was an inhalation injury that occurred while travelling in Vietnam, or exposure to the organophosphate pesticide Malathion several days prior. The explanted lung histology revealed ulcerating bronchitis with intense histiocytic infiltrates, bronchial luminal fibrosis and obstruction with scant, poorly formed granulomas. The patient thrived with stable lung function and had minimal complications initially post‐transplantation. However, 6 years after lung transplantation and without re‐exposure, the patient re‐developed ulcerative tracheobronchitis, which shared similar histopathologic features to airway involvement of Crohn’s disease. Gastrointestinal or other organ system involvement of Crohn’s disease was not established despite extensive investigations. A decision for phenotypic treatment with the TNF‐ α inhibitor, infliximab, was made with subsequent rapid improvement in the tracheobronchitis. Conclusion: This is the first case documented in the literature of ulcerative tracheobronchitis followed by intense bronchial web‐like stenoses caused by an unspecified autoimmune disease, treated by bilateral lung transplantation. The disease recurred after 6 years and responded to phenotypic management with the TNF‐ α inhibitor, infliximab. The patient will require careful monitoring given the risk of augmented immunosuppression and unknown disease trajectory.
- 1 January 2026
- Published by Wiley in Case Reports in Transplantation
- Vol. 2026 (1)
Open AccessRecurrent Cryptogenic Ulcerative Tracheobronchitis 6 Years After Lung Transplantation: Case Report
Background: Tracheobronchitis is an uncommon pattern of airway disease and is typically caused by infection, inhalation injury, infiltrative disorders and more rarely, systemic autoimmune disease. Rarer again is the development of bronchial webbing following tracheobronchitis. The underlying aetiology is usually identified through biopsy, culture or a detailed clinical history. We present a case of cryptogenic ulcerative tracheobronchitis with bronchial webbing being successfully managed by bilateral lung transplantation that has, however, been complicated by recurrence. Case Presentation: In 2019, Crowhurst et al. detailed the case of a patient who presented with dyspnoea and haemoptysis. Bronchoscopy revealed ulcerative tracheobronchitis and he subsequently formed recurrent web‐like stenoses of the central bronchi, leading to rapidly progressive type 2 respiratory failure; he received bilateral sequential lung transplantation for definitive management. At the time of transplant, the presumed diagnosis was an inhalation injury that occurred while travelling in Vietnam, or exposure to the organophosphate pesticide Malathion several days prior. The explanted lung histology revealed ulcerating bronchitis with intense histiocytic infiltrates, bronchial luminal fibrosis and obstruction with scant, poorly formed granulomas. The patient thrived with stable lung function and had minimal complications initially post‐transplantation. However, 6 years after lung transplantation and without re‐exposure, the patient re‐developed ulcerative tracheobronchitis, which shared similar histopathologic features to airway involvement of Crohn’s disease. Gastrointestinal or other organ system involvement of Crohn’s disease was not established despite extensive investigations. A decision for phenotypic treatment with the TNF‐ α inhibitor, infliximab, was made with subsequent rapid improvement in the tracheobronchitis. Conclusion: This is the first case documented in the literature of ulcerative tracheobronchitis followed by intense bronchial web‐like stenoses caused by an unspecified autoimmune disease, treated by bilateral lung transplantation. The disease recurred after 6 years and responded to phenotypic management with the TNF‐ α inhibitor, infliximab. The patient will require careful monitoring given the risk of augmented immunosuppression and unknown disease trajectory.
- Open Access
Neural aperiodic activity as a novel test of vigilance: a proof-of concept, retrospective study of patients undergoing MWT
The maintenance of wakefulness test (MWT) measures the ability of an individual to maintain wakefulness in soporific conditions and despite limitations remains the mainstay of vigilance testing. Wake and sleep states are traditionally characterised by oscillatory activity on electroencephalogram (EEG) but there is a less utilised non-oscillatory component of background neural aperiodic activity which can be derived from EEG raw data and represented as an exponent or a gradient (1/f slope). There is emerging evidence that aperiodic activity can be used to predict cortical activity. The aim of this study is to assess the use of aperiodic activity as a novel neurobiological marker of vigilance. EEGs (4 x 50) from 50 patients who underwent the MWT between 2009 and 2023 at a single centre were analysed to determine their aperiodic activity. Statistical analyses utilising linear mixed models and linear regression were performed to assess the relationship between aperiodic exponent, aperiodic intercept and mean sleep latency. Linear mixed-effects modelling revealed that more negative aperiodic exponents represented by steeper 1/f slopes were associated with longer sleep onset latencies (β=-8.08, p=0.002). Similarly, higher aperiodic intercept scores were associated with longer sleep onset latencies (β=2.36, p=0.01). This study provides proof-of-concept that aperiodic activity may be predictive of vigilance. Given its practicality, cost-effectiveness and lower demand on health staff and patient time, it is suggested that aperiodic activity as a test of vigilance testing offers not only greater diagnostic objectivity but benefits to already resource-limited healthcare systems.
Open AccessNeural aperiodic activity as a novel test of vigilance: a proof-of concept, retrospective study of patients undergoing MWT
The maintenance of wakefulness test (MWT) measures the ability of an individual to maintain wakefulness in soporific conditions and despite limitations remains the mainstay of vigilance testing. Wake and sleep states are traditionally characterised by oscillatory activity on electroencephalogram (EEG) but there is a less utilised non-oscillatory component of background neural aperiodic activity which can be derived from EEG raw data and represented as an exponent or a gradient (1/f slope). There is emerging evidence that aperiodic activity can be used to predict cortical activity. The aim of this study is to assess the use of aperiodic activity as a novel neurobiological marker of vigilance. EEGs (4 x 50) from 50 patients who underwent the MWT between 2009 and 2023 at a single centre were analysed to determine their aperiodic activity. Statistical analyses utilising linear mixed models and linear regression were performed to assess the relationship between aperiodic exponent, aperiodic intercept and mean sleep latency. Linear mixed-effects modelling revealed that more negative aperiodic exponents represented by steeper 1/f slopes were associated with longer sleep onset latencies (β=-8.08, p=0.002). Similarly, higher aperiodic intercept scores were associated with longer sleep onset latencies (β=2.36, p=0.01). This study provides proof-of-concept that aperiodic activity may be predictive of vigilance. Given its practicality, cost-effectiveness and lower demand on health staff and patient time, it is suggested that aperiodic activity as a test of vigilance testing offers not only greater diagnostic objectivity but benefits to already resource-limited healthcare systems.
- Open Access
- 10 November 2021
- Published by Wiley in Respirology Case Reports
- Vol. 9 (12) , e0876
A curious case of asphyxiating thoracic dystrophy in an adult
Asphyxiating thoracic dystrophy (ATD), also known as Jeune syndrome, is a rare autosomal recessive chondrodysplasia that most commonly manifests as shortening of long bones and ribs, as well as frequent extra‐skeletal organ involvement. It is typically diagnosed in infancy or early childhood following episodes of respiratory distress or failure, in conjunction with characteristic physical findings, and is often fatal. The genetic heterogeneity of this disease, however, means there is varying severity of symptoms and physical manifestations. In this report, we describe a 57‐year‐old man with his first presentation of respiratory failure, with a history and physical findings consistent with ATD, a diagnosis previously unknown to the patient.
- 10 November 2021
- Published by Wiley in Respirology Case Reports
- Vol. 9 (12) , e0876
Open AccessA curious case of asphyxiating thoracic dystrophy in an adult
Asphyxiating thoracic dystrophy (ATD), also known as Jeune syndrome, is a rare autosomal recessive chondrodysplasia that most commonly manifests as shortening of long bones and ribs, as well as frequent extra‐skeletal organ involvement. It is typically diagnosed in infancy or early childhood following episodes of respiratory distress or failure, in conjunction with characteristic physical findings, and is often fatal. The genetic heterogeneity of this disease, however, means there is varying severity of symptoms and physical manifestations. In this report, we describe a 57‐year‐old man with his first presentation of respiratory failure, with a history and physical findings consistent with ATD, a diagnosis previously unknown to the patient.